Board of Directors

The composition of Novozymes' Board of Directors following the Annual Shareholders' Meeting on February 24, 2016.

 

 

 

 
Henrik.jpg
Henrik Gürtler
Born 1953. MSc (Engineering), chemical engineer. Chairman of the Board since 2000. Elected for one year at a time.

Board positions
Member: Ejendomsmægler Kim Svane A/S
 
Special competencies
In-depth knowledge of Novozymes’ business, and expertise in managing and working in an international biotechnology company.
 
 
Jørgen.jpg 
 
 
Jørgen Buhl Rasmussen
Born 1955, MSc (Economics and Business Administration), MBA. Adjunct professor at Copenhagen Business School. Member of the Board since 2011. Member of the Audit Committee. Elected for one year at a time.
 
Board positions
Chairman: F. Uhrenholt A/S
Member: IFC Europe A/S, Axcel Advisory Board, DI's Permanent Committee on Business Policies
 
Special competencies
International business and management experience, specifically within sales, marketing, branding and acquisitions.
 
 
Heinz



Heinz-Jürgen Bertram

Born 1958. President & CEO, Symrise AG, Germany. Doctoral degree, PhD (Chemistry). Member of the Board since 2015. Elected for one year at a time. 

Board positions
None
 
Special competencies
International business and management experience, specifically converting research and biotechnology into commercial products and solutions.
Lars Green.jpg

Lars Green

Born 1967. Senior Vice President, Finance & Operations, Novo Nordisk Inc. (USA), MSc (Business Administration). Member of the Board since 2014. Chairman of the Audit Committee. Elected for one year at a time.

 
Board positions
None
 
Special competencies
In-depth knowledge of the Novo Group's business, international experience from managing global biotech and biopharma companies, and financial and accounting expertise.
Agnete.jpg
 
 
Agnete Raaschou-Nielsen
Born 1957. PhD (Economics). Vice Chairman. Member of the Board since 2011. Member of the Audit Committee. Elected for one year at a time.
 
Board positions
Chairman: Arkil Holding A/S, Brdr. Hartmann A/S, Danske Invest
Vice Chairman: Dalhoff Larsen & Horneman A/S,  Solar A/S
Member: Aktieselskabet Schouw & Co., Danske Invest Management A/S
Member of Audit Committees:
Aktieselskabet Schouw & Co., Solar A/S
 
Special competencies
Expertise in business development and acquisitions, macroeconomics and intellectual property rights.
 
 
 
Matthias-Uhlen
 
 

Mathias Uhlén

Born 1954. Professor, the Royal Institute of Technology (Kungliga Tekniska Högskolan), Sweden, and the Technical University of Denmark (DTU). Member of the Board since 2007. Elected for one year at a time.

 
Board positions
Chairman: Atlas Antibodies AB, Antibodypedia AB
Vice Chairman: Affibody AB
Member: Alligator AB, Bure Equity AB, SweTree Technologies AB
 
Special competencies
Broad experience in research and biotechnology.
Lena.jpg
 
 

Lena Bech Holskov

Born 1967. Safety Adviser. Employee representative. Member of the Board since 2013. Elected for four years at a time.

 
 
 

Anders Hentze Knudsen

Born 1959. Senior Operator. Employee representative. Member of the Board since 2013. Elected for four years at a time.

Lars Bo Køppler.jpg
 
 
Lars Bo Køppler
Born 1962. Technician. Employee representative. Member of the Board since 2010. Elected for four years at a time.
 
Employee elected member of the board of Novo Nordisk Foundation since 2014. Elected for a four year period.
 
​​​